Overall proportion of industry and non-industry income is: 86.4% industry income vs 13.6% non-industry income. Please find below a list of Industry Partners and related contributions for the financial year 2019:
Industry1 related income (2019)
|Name of company/funder||Amount of income2||Percentage of overall budget|
|Bristol-Myers-Squibb (BMS - formerly Celgene)||€ 167,796||0,9%|
|Canopy Growth||€ 11,310||13,6%|
 This should reflect the overall funding received from industry, including, e.g. projects, conferences, etc.
Code of Conduct
On a regular basis, EMSP also collaborates with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Our approach is transparent and rules-based, as set out in our Code of Conduct.